Mission possible: Achieving glycemic targets with basal insulin using forced titration and pattern management

被引：0
|
作者：
Anthony L. McCall
机构：
来源：
Current Diabetes Reports | 2004年 / 4卷 / 5期
关键词：
Hypoglycemia; Fasting Plasma Glucose; Insulin Glargine; Basal Insulin; United Kingdom Prospective Diabetes Study;
D O I：
10.1007/s11892-004-0032-6
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：327 / 329
页数：2
相关论文
共 50 条
  • [31] Gaps Remain for Achieving Guideline-Recommended and Individualized HbA1c Targets for People with Type 1 and Type 2 Diabetes Using Mealtime Insulin or Basal-Only Insulin
    Hankosky, Emily R.
    Schapiro, David
    Gunn, Karli B.
    Lubelczyk, Elizabeth
    Mitroi, Jessica
    Nelson, David R.
    [J]. DIABETES, 2022, 71
  • [32] Achievement of Glycemic Targets when Switching from Basal-Bolus Therapy to V-Go for Insulin Delivery in Type 2 Diabetes
    Hundal, Ripu S.
    Kowalyk, Stephan
    Cases, Jane
    Al-Karadsheh, Amer
    Wakim, Amanda P.
    Doyle, Melissa
    Sink, John H., II
    Spence, Adrienne
    Brewer, Jamie L.
    Nikkel, Carla C.
    [J]. DIABETES, 2018, 67
  • [33] A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus
    Candido, Riccardo
    Wyne, Kathleen
    Romoli, Ester
    [J]. DIABETES THERAPY, 2018, 9 (03) : 927 - 949
  • [34] A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus
    Riccardo Candido
    Kathleen Wyne
    Ester Romoli
    [J]. Diabetes Therapy, 2018, 9 : 927 - 949
  • [35] GlucoTab-Based Basal-Bolus Insulin Therapy for Inpatient Glycemic Control Using an Ultra-Long-Acting Insulin Analog
    Mader, Julia K.
    Donsa, Klaus
    Aberer, Felix
    Smajic, Edin
    Lanz, Christian
    Lichtenegger, Katharina M.
    Spat, Stephan
    Hoell, Bernhard
    Beck, Peter
    Pieber, Thomas R.
    Plank, Johannes
    [J]. DIABETES, 2017, 66 : A277 - A277
  • [36] Achieving postprandial glucose control with lixisenatide improves glycemic control in patients with type 2 diabetes on basal insulin: a post-hoc analysis of pooled data
    Jaime A. Davidson
    William Stager
    Sachin Paranjape
    Rachele Berria
    Lawrence A. Leiter
    [J]. Clinical Diabetes and Endocrinology, 6 (1)
  • [37] Pramlintide improved glycemic control without increased risk of hypoglycemia in patients with type 2 diabetes using basal insulin
    Lutz, Karen
    Maier, Holly
    Zhang, Bei
    Frias, Juan
    [J]. DIABETES, 2007, 56 : A143 - A143
  • [38] EVALUATION OF GLYCEMIC CONTROL USING AN ALGORITHM FOR BASAL BOLUS INSULIN THERAPY IN HOSPITALISED PATIENTS WITH DIABETES MELLITUS TYPE 2
    Mader, J. K.
    Neubauer, K. M.
    Schaupp, L.
    Aberer, F.
    Augustin, T.
    Spat, S.
    Hoell, B.
    Beck, P.
    Plank, J.
    Pieber, T. R.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 : A8 - A8
  • [39] Glycemic Management Practice Guideline Combined with a Multidisciplinary Champion Team Approach Increased the Use of Basal Bolus Insulin Regimen and Reduced the Use of Sliding Scale Insulin
    Bogun, Magdalena M.
    Zagoren, Eleanor
    Ackerman, Kevin
    Ciolek, Alana M.
    [J]. DIABETES, 2019, 68
  • [40] GLYCEMIC MANAGEMENT USING SIMPLE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IN PATIENTS WITH TYPE 2 DIABETES
    Mader, J. K.
    Lilly, L. C.
    Warner, J. L.
    Pieber, T. R.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2013, 15 : A138 - A138
12345